BioNTech

BNTX | NASDAQ | 17 Followers
$101.72 +4.01% $3.92
Follow
Loading...

Fair Price

$36.82
Overvalued by 10.8%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

BioNTech SE is a German biotechnology company focused on the research and development of innovative drugs and therapeutic approaches. The company is well-known for its groundbreaking research and development of mRNA (messenger RNA) technology, which serves as the basis for drug and vaccine development. BioNTech collaborates with pharmaceutical and research partners worldwide and focuses on addressing serious diseases such as cancer, infectious diseases, and others. It gained significant recognition through its collaboration with Pfizer on the development and distribution of the COVID-19 vaccine, which became the first mRNA vaccine approved for emergency use. BioNTech SE adheres to high standards of scientific research and innovation and emphasizes the potential to change the way diseases are treated and prevented. Investing in BioNTech SE (BNTX) shares may be an interesting choice for investors who follow the biotechnology sector and seek investment opportunities in an innovative company with promising medical technologies.

Feed

Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade